Boucherat et al. reported increased expression levels of HDAC6 within the lungs and distal PAs in both PAH patients and animal models induced by MCT or Sugen/hypoxia (Su/Hx) experiments [63]. The gene discussed is HDAC6; the disease is pulmonary arterial hypertension.